Ro vs Hims & Hers for GLP-1 (2026): An Honest Comparison

Both Ro and Hims & Hers are big, well-known telehealth brands that will prescribe a GLP-1 online — and in 2026 they’ve become more alike than they used to be. Here’s an honest, fact-checked side-by-side to help you decide. We are not affiliated with either company, and every claim below is sourced.

Educational content, not medical advice. Whether a GLP-1 — and which provider — is right for you is a decision for you and a licensed clinician. Pricing in this market changes often; confirm current figures on each provider’s official site before enrolling.

The short verdict

• Choose Ro if you want the most transparent published pricing (Ro shows exact per-dose costs), active insurance help (a dedicated concierge), prepay membership discounts, and the lower-risk option on trust right now.
• Choose Hims & Hers if you want a fast, fully asynchronous process (no video visits) and can pair a commercial-insurance savings card to lower the cost of branded Wegovy — while weighing the pending FTC lawsuit below.

Because their prices now largely overlap, the real deciding factors are transparency, insurance help, and trust (favoring Ro) versus async convenience (favoring Hims).

Medication: both are brand-name now

The biggest 2026 change: both are effectively brand-name-only for new patients. Ro’s current program prescribes FDA-approved medication (Wegovy pill and pen, Zepbound), with no compounded options listed. Hims exited compounded semaglutide after settling a patent lawsuit with Novo Nordisk in March 2026, and now offers FDA-approved branded GLP-1s to new patients.

Why this matters: compounded GLP-1s were cheaper but are not FDA-approved and their availability is being restricted. So on the medication-safety axis, both providers are now on the same, sturdier footing than the compounding-era telehealth companies.

Pricing: a two-part cost, and this is where they differ

Both use the same structure that trips people up: a membership fee plus a separate medication cost. The advertised membership is not your total.

Ro’s edge here is transparency: it publishes an exact per-dose price table. Hims’s public pricing is harder to pin down and sources conflict, so confirm the current all-in number on hims.com before you commit. Either way, run your real total through our all-in cost calculator.

Insurance

Both are fundamentally cash-pay platforms, but they help differently. Ro markets a dedicated insurance concierge that actively works to get your medication covered at a retail pharmacy. Hims doesn’t bill insurance directly, but if you have commercial insurance and use a Novo Nordisk savings card, branded Wegovy can come down substantially. If using insurance matters to you, Ro’s help is more formalized — and it’s worth calling your insurer first regardless (our free insurance call script helps).

What’s included

• Ro: FDA-approved medication access, a treatment plan, unlimited provider messaging, side-effect management, dose/weight tracking, 1:1 health coaching, insurance concierge, and labs if necessary. App-based.
• Hims & Hers: online eligibility screening and clinical evaluation, asynchronous consultations (no video visits), unlimited messaging, monthly check-ins, dose adjustments, and digital tracking. Labs aren’t clearly part of every plan.

Consumer reviews for both note that clinical oversight is relatively light — these are prescription-forward services, not a substitute for hands-on care.

Trust and track record — the honest part

This is where they genuinely diverge in 2026.

Hims & Hers is facing an active FTC lawsuit. On July 29, 2026, the Federal Trade Commission — joined by the State of Utah and Los Angeles County — filed suit alleging that Hims shared sensitive consumer health data with Meta and Snap despite its privacy marketing, charged some consumers almost immediately after intake without a genuine provider consultation, and made subscriptions hard to cancel. These are allegations that have not been proven in court, and Hims will have the opportunity to respond. We’re not passing judgment — but for a decision about who handles your health data and your recurring bill, it’s material information you should have. (Hims also settled the separate Novo Nordisk patent case in March 2026.)

Ro, by contrast, has no active government action we could find as of this writing. Its common complaints are the more ordinary kind — confusion over the two-part pricing and wanting prices shown sooner. That’s a meaningful difference on the trust axis right now.

So which is better for you?

There’s no universal winner — but based on the verified facts:

• Ro is the stronger all-around pick today for most people: transparent pricing, active insurance help, prepay discounts, and no active regulatory cloud.
• Hims can still fit if you specifically want the fast, fully-online experience and can leverage an insurance savings card — provided you’re comfortable with the pending FTC matter and confirm the current pricing yourself.

Whichever way you lean, compare the all-in cost (membership + medication + any labs), not the headline, and make the final call with a licensed clinician.

Want the full field, not just these two? See our honest comparison of all the major GLP-1 providers, or take the 2-minute provider match.